Caspase activation - stepping on the gas or releasing the brakes? Lessons from humans and flies

Guy S Salvesen1, John M Abrams

  • 1Program in Apoptosis and Cell Death Research, The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92122, USA. gsalvesen@burnham.org

Oncogene
|April 13, 2004
PubMed

Insights

This study reviews caspase regulation in apoptosis, highlighting distinct control mechanisms in humans and flies. Understanding these pathways is key for developing cancer therapies that restore cell death.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Apoptosis, or programmed cell death, is executed by caspases, a family of proteases.
  • Caspase activity is tightly regulated through zymogen activation and inhibition.
  • Distinct regulatory strategies exist in different organisms, such as humans and Drosophila.

Purpose of the Study:

  • To review the fundamental control points of caspase activity in apoptosis.
  • To compare and contrast caspase regulation in humans and Drosophila.
  • To provide a foundation for therapeutic strategies targeting cancer cell immortality.

Main Methods:

  • Literature review of studies on caspase function and regulation.
  • Comparative analysis of molecular mechanisms in different model organisms.
  • Synthesis of evidence regarding zymogen activation and protease inhibition.

Main Results:

  • Two primary control points for caspase activity: zymogen activation and protease inhibition.
  • Human caspase activity is primarily driven by zymogen activation.
  • Drosophila caspase activity is significantly influenced by the derepression of caspase inhibitors.

Conclusions:

  • Caspase regulation differs between humans and Drosophila, with distinct emphasis on activation versus inhibition.
  • Understanding these differences is crucial for developing targeted cancer therapies.
  • Restoring normal apoptotic mechanisms could combat cancer cell immortality.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.